This document describes a study evaluating positively charged liposaccharide derivatives as oral absorption enhancers for delivering anionic drugs. Positively charged liposaccharide derivatives were synthesized and combined with the anionic model drug piperacillin through ion pairing. The conjugates were evaluated in vitro and in vivo to assess antimicrobial activity, plasma stability, permeability across Caco-2 cell monolayers, and oral absorption. Results showed that ion pairing the liposaccharide derivatives with piperacillin improved permeability in Caco-2 cells without altering antimicrobial activity, indicating potential as oral absorption enhancers.
Drug and gene delivery vehicles are biocompatible devices that can carry therapeutic components in the body. Synthetic vehicles include block copolymers, liposomes, dendrimers, and magnetic nanoparticles. Block copolymers form micelles with hydrophobic cores that can encapsulate drugs. Liposomes are phospholipid vesicles that can encapsulate both hydrophilic and hydrophobic drugs. Dendrimers are nanoscale polymers that can be functionalized to target drugs. Magnetic nanoparticles can be used for drug delivery, hyperthermia cancer treatment, and as MRI contrast agents. These vehicles aim to improve drug bioavailability and targeting while decreasing toxicity.
This document describes the synthesis and characterization of a series of anionic liposaccharide derivatives intended to act as absorption enhancers and improve oral bioavailability of drugs. The liposaccharides were designed with a lipophilic lipid side chain and a hydrophilic head containing glucose and glutamic acid. Isothermal titration calorimetry was used to determine the critical aggregation concentrations and thermodynamic profiles of the liposaccharides. Two liposaccharides formed nanoparticles below 100 nm and had critical aggregation concentrations below 0.325 mM, indicating favorable aggregation in aqueous solution driven by entropy.
The document describes the design, synthesis, and testing of novel lipopeptide conjugates as potential antimicrobial agents. A library of conjugates was designed based on a template consisting of a hydrophobic moiety, dipeptide, and spermidine. Conjugates containing linoleic acid exhibited potent antibacterial activity against both Gram-positive and Gram-negative bacteria. Structure-activity relationships revealed that optimal activity required a hydrophobicity of 50-70% and a minimum charge of +2. Active conjugates were found to have different modes of action, damaging bacterial cell membranes and DNA. Two conjugates showed selective membrane disruption of pathogenic MRSA and were identified as promising leads for further optimization and development as antimicrobial agents.
Development and characterization of anionic liposaccharides for enhanced oralAdel Abdelrahim, PhD
The document describes the development and characterization of novel anionic liposaccharide derivatives for enhancing oral drug delivery. Liposaccharides containing d-glucose and lipoamino acids were synthesized. Their critical aggregation concentration and thermodynamic profiles were determined using isothermal titration microcalorimetry. The liposaccharides were found to be non-toxic and did not cause hemolysis or reduce cell viability. When mixed with the model drug tobramycin, one of the liposaccharides formed aggregates around 200 nm and increased tobramycin's partitioning between n-octanol and water, suggesting it may enhance the oral absorption of hydrophilic drugs.
This study synthesized eight new fluorinated quinazolinone-sulphonamide hybrid compounds and evaluated their anticancer activity. One compound showed significant anticancer activity with low toxicity compared to the reference drug mitoxantrone. Biological assays also demonstrated moderate anticancer activity for the compounds compared to reference drugs. The compound with the best activity profile was identified for further evaluation as an anticancer agent.
Segment and Sequential Stratergies for Solution Phase Peptide SynthesisRUTUJAPAWAR32
This document discusses strategies for solution phase peptide synthesis, including linear and convergent approaches. Linear strategies involve stepwise coupling of amino acids from the C to N terminus, while convergent strategies condense pre-made peptide segments. Both approaches can be used, considering factors like the target peptide complexity, protection schemes, and economics. Convergent synthesis has advantages like dividing labor and being closer to starting materials, but linear strategies may be better for smaller peptides due to issues with segment coupling like low concentration and solubility. Common techniques discussed include manual synthesis using syringes or the tea bag method, and automated synthesis systems.
This document describes an inter-laboratory evaluation study conducted to validate the use of the 1,1-diphenyl-2-picrylhydrazyl (DPPH) assay as a standard method for evaluating the antioxidant capacity of food additives. Fourteen laboratories participated in the study. Five analytical samples - four existing food additives (tea extract, grape seed extract, enju extract, and d-α-tocopherol) and Trolox - were evaluated using the DPPH assay. The results showed good repeatability for measuring antioxidant capacity within laboratories, but greater variability between laboratories. However, expressing the results as Trolox equivalent antioxidant capacity reduced inter-laboratory variability, suggesting the DPPH assay could be
Drug and gene delivery vehicles are biocompatible devices that can carry therapeutic components in the body. Synthetic vehicles include block copolymers, liposomes, dendrimers, and magnetic nanoparticles. Block copolymers form micelles with hydrophobic cores that can encapsulate drugs. Liposomes are phospholipid vesicles that can encapsulate both hydrophilic and hydrophobic drugs. Dendrimers are nanoscale polymers that can be functionalized to target drugs. Magnetic nanoparticles can be used for drug delivery, hyperthermia cancer treatment, and as MRI contrast agents. These vehicles aim to improve drug bioavailability and targeting while decreasing toxicity.
This document describes the synthesis and characterization of a series of anionic liposaccharide derivatives intended to act as absorption enhancers and improve oral bioavailability of drugs. The liposaccharides were designed with a lipophilic lipid side chain and a hydrophilic head containing glucose and glutamic acid. Isothermal titration calorimetry was used to determine the critical aggregation concentrations and thermodynamic profiles of the liposaccharides. Two liposaccharides formed nanoparticles below 100 nm and had critical aggregation concentrations below 0.325 mM, indicating favorable aggregation in aqueous solution driven by entropy.
The document describes the design, synthesis, and testing of novel lipopeptide conjugates as potential antimicrobial agents. A library of conjugates was designed based on a template consisting of a hydrophobic moiety, dipeptide, and spermidine. Conjugates containing linoleic acid exhibited potent antibacterial activity against both Gram-positive and Gram-negative bacteria. Structure-activity relationships revealed that optimal activity required a hydrophobicity of 50-70% and a minimum charge of +2. Active conjugates were found to have different modes of action, damaging bacterial cell membranes and DNA. Two conjugates showed selective membrane disruption of pathogenic MRSA and were identified as promising leads for further optimization and development as antimicrobial agents.
Development and characterization of anionic liposaccharides for enhanced oralAdel Abdelrahim, PhD
The document describes the development and characterization of novel anionic liposaccharide derivatives for enhancing oral drug delivery. Liposaccharides containing d-glucose and lipoamino acids were synthesized. Their critical aggregation concentration and thermodynamic profiles were determined using isothermal titration microcalorimetry. The liposaccharides were found to be non-toxic and did not cause hemolysis or reduce cell viability. When mixed with the model drug tobramycin, one of the liposaccharides formed aggregates around 200 nm and increased tobramycin's partitioning between n-octanol and water, suggesting it may enhance the oral absorption of hydrophilic drugs.
This study synthesized eight new fluorinated quinazolinone-sulphonamide hybrid compounds and evaluated their anticancer activity. One compound showed significant anticancer activity with low toxicity compared to the reference drug mitoxantrone. Biological assays also demonstrated moderate anticancer activity for the compounds compared to reference drugs. The compound with the best activity profile was identified for further evaluation as an anticancer agent.
Segment and Sequential Stratergies for Solution Phase Peptide SynthesisRUTUJAPAWAR32
This document discusses strategies for solution phase peptide synthesis, including linear and convergent approaches. Linear strategies involve stepwise coupling of amino acids from the C to N terminus, while convergent strategies condense pre-made peptide segments. Both approaches can be used, considering factors like the target peptide complexity, protection schemes, and economics. Convergent synthesis has advantages like dividing labor and being closer to starting materials, but linear strategies may be better for smaller peptides due to issues with segment coupling like low concentration and solubility. Common techniques discussed include manual synthesis using syringes or the tea bag method, and automated synthesis systems.
This document describes an inter-laboratory evaluation study conducted to validate the use of the 1,1-diphenyl-2-picrylhydrazyl (DPPH) assay as a standard method for evaluating the antioxidant capacity of food additives. Fourteen laboratories participated in the study. Five analytical samples - four existing food additives (tea extract, grape seed extract, enju extract, and d-α-tocopherol) and Trolox - were evaluated using the DPPH assay. The results showed good repeatability for measuring antioxidant capacity within laboratories, but greater variability between laboratories. However, expressing the results as Trolox equivalent antioxidant capacity reduced inter-laboratory variability, suggesting the DPPH assay could be
Experimental and theoretical solubility advantage screening of bi-component s...Maciej Przybyłek
This document describes an experimental and theoretical study to screen potential solubilizers for curcumin. In the experimental phase, the solubility of curcumin was measured in binary mixtures with 24 excipients. The highest solubility enhancement was found with pyrogallol, caffeine, theophylline, and nicotinamide. A theoretical QSPR model was then developed using molecular descriptors to predict solubility. This model was applied to screen over 230,000 compounds and predict solubility for curcumin analogs and naturally occurring turmerones to identify new excipients.
This document describes a study that prepared and evaluated carvedilol-loaded solid lipid nanoparticles (SLNs) for oral drug delivery. Compritol 888 ATO (COMP) was selected as the lipid material based on its solubility parameter relative to carvedilol. Design of experiments was used to optimize the concentrations of COMP and Poloxamer 188 surfactant in blank SLNs and carvedilol-loaded SLNs. The optimized formulation containing 7.5% COMP, 5.0% Poloxamer 188, and 1.11% carvedilol had a particle size of 161 nm and 94.8% drug entrapment efficiency. In vitro studies showed the SLNs protected carvedilol from acidic environments and
A team of scientists developed an optimized peptide toxin derived from ShK, a peptide from sea anemone venom, for potential treatment of autoimmune diseases. They used a systematic approach called MAPS (Multi Attribute Positional Scan) analoging to chemically synthesize 132 variants of ShK with single amino acid substitutions throughout the peptide. These variants were tested for their ability to inhibit the Kv1.3 potassium ion channel while sparing the closely related Kv1.1 channel. Two lead variants showed improved selectivity for Kv1.3 over Kv1.1. One variant was further modified with a PEG polymer to improve its pharmacokinetic properties. In primate studies, the PEGylated peptide
This document discusses key drug-like properties that are important for drug discovery. It covers properties such as solubility, permeability, metabolic stability and how they impact pharmacokinetics and bioavailability. Modifying a molecule's structure can optimize these properties. For example, adding ionizable groups can increase solubility while reducing logP or molecular weight. Understanding how changes impact multiple properties is crucial for medicinal chemists to design drug candidates with balanced absorption and response profiles.
Antioxidant activity of curcuma longa l., novel foodstuffNguyen Vinh
This study evaluated the antioxidant activity of different fractions from a methanolic extract of Curcuma longa L. (turmeric). The ethyl acetate (EtOAc) fraction showed the highest antioxidant activity in DPPH, ABTS, and FRAP assays. It also contained the highest level of total phenolic compounds. There was a strong positive correlation between total phenolic content and antioxidant activity across all fractions, suggesting phenolic compounds contribute significantly to the antioxidant effects. In conclusion, the EtOAc fraction of C. longa demonstrated strong antioxidant potential and is a promising source of natural antioxidant compounds.
Lipase catalyzed process for biodiesel production protein engineering and lip...Melike Şeyma Kadayıfçı
This review document discusses the use of lipases in biodiesel production. It covers lipase engineering approaches like directed evolution and rational design to improve properties such as thermostability and activity. It also discusses lipase production methods like host strain selection and metabolic engineering. The goal is to develop high-performance lipases through these techniques to enable large-scale commercialization of lipase-catalyzed biodiesel production as an alternative to fossil fuels.
ZQL-journal of material chemistry B校稿前版Quanlei Zhu
This document summarizes a study investigating the use of poly-L-glutamic acid (PGA)-based ternary nanocomplex (TC) to improve the oral absorption of doxorubicin hydrochloride (Dox·HCl), a poorly permeable drug. The TC was formulated using PGA and another polymer, poly(β-amino esters) (PAE). In vitro studies showed the TC had higher stability than the binary Dox·HCl/PGA complex and was able to achieve 5.2-fold higher cellular uptake in Caco-2 cells. Mechanistic studies indicated the enhanced absorption was due to active endocytosis mediated by interactions between PGA and membrane-bound γ-
JBEI Research Highlights - November 2018 Irina Silva
This document discusses recent advances in x-ray hydroxyl radical footprinting at the Advanced Light Source synchrotron. It compares dose response curves and mass spectrometry results from focused and unfocused white light sources. It also describes developing "drop-on-demand" methodologies to increase sample dose while maintaining microsecond exposure times, which enables high-dose experiments while minimizing sample volume. Preliminary experiments demonstrate this approach yields high quality data. The document contributes to improving synchrotron hydroxyl radical footprinting techniques for investigating protein and nucleic acid structures.
APPLICATIONS OF MULTICOMPONENT ASSEMBLY PROCESSES TO THE FACILE SYNTHESES OF ...JamesSahn
Several multicomponent assembly processes have been developed for the synthesis of intermediates that may be elaborated by a variety of cyclizations to generate a diverse array of highly functionalized heterocycles from readily-available starting materials. The overall approach enables the efficient preparation of libraries of small molecules derived from fused, privileged scaffolds. Source: Heterocycles 84:2 2012 pg 1089-1112
This document is a letter informing the author that changes made to the HTML version of their article will be added before publication but are not reflected in the attached PDF file. The letter also notes that the PDF should not be used for submitting corrections. The PDF then contains a research article examining the structure-activity relationships of redox active thiol peroxidase mimic compounds. The study relates the ability of organoselenium and organotellurium compounds to catalyze the oxidation of glutathione and dihydrolipoic acid to their cytotoxicity and ability to act as antioxidants or prooxidants in cancer cells. The results show dihydrolipoic acid oxidation correlates with cytotoxicity and prooxidant action, allowing prediction of compound
Protein and-peptide-drug-delivery-systemsGaurav Kr
The document discusses protein and peptide drug delivery systems. It begins by defining proteins and peptides, noting that proteins are molecules composed of over 50 amino acids, while peptides are molecules composed of less than 50 amino acids. It then discusses how scientific advances in molecular and cell biology have led to the development of recombinant DNA and hybridoma technology to produce protein products. The document provides examples of marketed protein and peptide drugs and discusses challenges with delivering these drugs orally due to their large molecular size and susceptibility to enzymatic degradation. It explores approaches to protein and peptide delivery including non-parenteral systemic delivery methods and various considerations for developing delivery systems for these pharmaceuticals.
This document summarizes a seminar presentation on fermentation. It discusses the history of fermentation, types of fermentation including aerobic and anaerobic, types of fermentors/bioreactors, and the industrial production of two important antibiotics - penicillin and streptomycin. For penicillin production, it describes the fermentation process including inoculum preparation, production medium, fermentation conditions, and recovery/purification. For streptomycin, it discusses the producing organism, industrial production process involving inoculum, medium, fermentation phases and conditions, and harvest/recovery methods.
This document provides an overview of phytosomes, which are novel drug delivery systems that combine hydrophilic plant extracts with phospholipids. Some key points:
- Phytosomes have enhanced bioavailability compared to simple herbal extracts as they can better cross lipid membranes and reach circulation.
- They are prepared using solvent evaporation methods, forming chemical bonds between phospholipids and phytoconstituents.
- Popular herbal extracts made into phytosomes include milk thistle, grape seed, green tea, and curcumin, to improve absorption and effects.
- Marketed phytosome products provide hepatoprotection, antioxidant, anti-aging, brain protection, and other benefits, demonstrating their
Pharma supplements recombinant proteins as excipients Stephen Berezenko
1) The document discusses challenges in formulating biotherapeutics like proteins and how commonly used excipients like gelatin and human serum albumin have issues related to purity, consistency, and potential risk of transmitting diseases.
2) It describes how recombinant DNA technology has been used to produce recombinant versions of gelatin and human serum albumin as excipients that are highly pure, consistent, and avoid risks from animal or human sources.
3) Recombinant human albumin called Recombumin has been commercially developed and clinically tested as a safer alternative to use in biotherapeutic formulations compared to traditional excipients from animal or human sources.
This document describes a study that synthesized novel 2,3-dihydro-1H-inden-1-one chalcone-like compounds and their hydroxyl derivatives to evaluate their inhibitory effects on mushroom tyrosinase activity. Two compounds, 2a and 2b, inhibited tyrosinase's diphenolase activity in a dose-dependent manner, with IC50 values lower than the positive control, kojic acid. Kinetic analysis showed that compounds 2a and 2b are reversible competitive inhibitors of tyrosinase. Compound 2b, with a 3,4-dihydroxy group resembling the substrate L-DOPA, exhibited the most potent inhibition, suggesting hydroxy-substituted 2,
Site specific targeting: chemical modifiction of structureManali Parab
Chemical modification can be used for site specific targeting of drugs. This involves introducing metabolically sensitive moieties into drug molecules to control their metabolism and deactivation after producing therapeutic effects. Two key approaches are soft drugs, which are designed to rapidly metabolize into inactive species, and chemical delivery systems (CDS), which use sequential enzymatic conversions to differentially distribute drugs. Computer-aided drug design can help optimize properties like binding affinity, absorption, and pharmacokinetics to aid in developing targeted drugs.
Evaluation of the Glucuronic Acid Production and Other Biological Activities...IJMER
The document evaluates the production of glucuronic acid and other biological activities of fermented sweetened black tea fermented with Kombucha culture alone or in combination with different Lactobacillus strains isolated from Kefir grains. Key findings include:
1) Lactobacillus casei increased glucuronic acid production in fermented tea by 39.6% compared to Kombucha culture alone.
2) Lactobacillus plantarum enhanced the antibacterial and antioxidant activities of fermented tea to a greater level than normal fermented tea or mixes with other Lactobacillus strains.
3) The study suggests certain Lactobacillus strains from Kefir grains
The document discusses biotransformation, which is the biological process by which organic compounds are modified by enzymes in microbial, plant, and animal cells. Microbial transformation is preferred over plant or animal cell transformation due to microbes having a higher surface-to-volume ratio, growth rate, and metabolism rate, as well as being easier to maintain sterility. Microbial transformations can occur under mild conditions and achieve high yields, regioselectivity, stereoselectivity, and multi-step conversions using different microorganisms.
Abraham Maslow nació en Brooklyn y tuvo una infancia solitaria. Estudió psicología y desarrolló la teoría de la jerarquía de necesidades humanas, que describe cómo las personas satisfacen necesidades fisiológicas, de seguridad, sociales, de estima y de autorrealización. Su teoría influyó en el pensamiento humanista y propuso que las personas buscan constantemente desarrollar su máximo potencial.
Experimental and theoretical solubility advantage screening of bi-component s...Maciej Przybyłek
This document describes an experimental and theoretical study to screen potential solubilizers for curcumin. In the experimental phase, the solubility of curcumin was measured in binary mixtures with 24 excipients. The highest solubility enhancement was found with pyrogallol, caffeine, theophylline, and nicotinamide. A theoretical QSPR model was then developed using molecular descriptors to predict solubility. This model was applied to screen over 230,000 compounds and predict solubility for curcumin analogs and naturally occurring turmerones to identify new excipients.
This document describes a study that prepared and evaluated carvedilol-loaded solid lipid nanoparticles (SLNs) for oral drug delivery. Compritol 888 ATO (COMP) was selected as the lipid material based on its solubility parameter relative to carvedilol. Design of experiments was used to optimize the concentrations of COMP and Poloxamer 188 surfactant in blank SLNs and carvedilol-loaded SLNs. The optimized formulation containing 7.5% COMP, 5.0% Poloxamer 188, and 1.11% carvedilol had a particle size of 161 nm and 94.8% drug entrapment efficiency. In vitro studies showed the SLNs protected carvedilol from acidic environments and
A team of scientists developed an optimized peptide toxin derived from ShK, a peptide from sea anemone venom, for potential treatment of autoimmune diseases. They used a systematic approach called MAPS (Multi Attribute Positional Scan) analoging to chemically synthesize 132 variants of ShK with single amino acid substitutions throughout the peptide. These variants were tested for their ability to inhibit the Kv1.3 potassium ion channel while sparing the closely related Kv1.1 channel. Two lead variants showed improved selectivity for Kv1.3 over Kv1.1. One variant was further modified with a PEG polymer to improve its pharmacokinetic properties. In primate studies, the PEGylated peptide
This document discusses key drug-like properties that are important for drug discovery. It covers properties such as solubility, permeability, metabolic stability and how they impact pharmacokinetics and bioavailability. Modifying a molecule's structure can optimize these properties. For example, adding ionizable groups can increase solubility while reducing logP or molecular weight. Understanding how changes impact multiple properties is crucial for medicinal chemists to design drug candidates with balanced absorption and response profiles.
Antioxidant activity of curcuma longa l., novel foodstuffNguyen Vinh
This study evaluated the antioxidant activity of different fractions from a methanolic extract of Curcuma longa L. (turmeric). The ethyl acetate (EtOAc) fraction showed the highest antioxidant activity in DPPH, ABTS, and FRAP assays. It also contained the highest level of total phenolic compounds. There was a strong positive correlation between total phenolic content and antioxidant activity across all fractions, suggesting phenolic compounds contribute significantly to the antioxidant effects. In conclusion, the EtOAc fraction of C. longa demonstrated strong antioxidant potential and is a promising source of natural antioxidant compounds.
Lipase catalyzed process for biodiesel production protein engineering and lip...Melike Şeyma Kadayıfçı
This review document discusses the use of lipases in biodiesel production. It covers lipase engineering approaches like directed evolution and rational design to improve properties such as thermostability and activity. It also discusses lipase production methods like host strain selection and metabolic engineering. The goal is to develop high-performance lipases through these techniques to enable large-scale commercialization of lipase-catalyzed biodiesel production as an alternative to fossil fuels.
ZQL-journal of material chemistry B校稿前版Quanlei Zhu
This document summarizes a study investigating the use of poly-L-glutamic acid (PGA)-based ternary nanocomplex (TC) to improve the oral absorption of doxorubicin hydrochloride (Dox·HCl), a poorly permeable drug. The TC was formulated using PGA and another polymer, poly(β-amino esters) (PAE). In vitro studies showed the TC had higher stability than the binary Dox·HCl/PGA complex and was able to achieve 5.2-fold higher cellular uptake in Caco-2 cells. Mechanistic studies indicated the enhanced absorption was due to active endocytosis mediated by interactions between PGA and membrane-bound γ-
JBEI Research Highlights - November 2018 Irina Silva
This document discusses recent advances in x-ray hydroxyl radical footprinting at the Advanced Light Source synchrotron. It compares dose response curves and mass spectrometry results from focused and unfocused white light sources. It also describes developing "drop-on-demand" methodologies to increase sample dose while maintaining microsecond exposure times, which enables high-dose experiments while minimizing sample volume. Preliminary experiments demonstrate this approach yields high quality data. The document contributes to improving synchrotron hydroxyl radical footprinting techniques for investigating protein and nucleic acid structures.
APPLICATIONS OF MULTICOMPONENT ASSEMBLY PROCESSES TO THE FACILE SYNTHESES OF ...JamesSahn
Several multicomponent assembly processes have been developed for the synthesis of intermediates that may be elaborated by a variety of cyclizations to generate a diverse array of highly functionalized heterocycles from readily-available starting materials. The overall approach enables the efficient preparation of libraries of small molecules derived from fused, privileged scaffolds. Source: Heterocycles 84:2 2012 pg 1089-1112
This document is a letter informing the author that changes made to the HTML version of their article will be added before publication but are not reflected in the attached PDF file. The letter also notes that the PDF should not be used for submitting corrections. The PDF then contains a research article examining the structure-activity relationships of redox active thiol peroxidase mimic compounds. The study relates the ability of organoselenium and organotellurium compounds to catalyze the oxidation of glutathione and dihydrolipoic acid to their cytotoxicity and ability to act as antioxidants or prooxidants in cancer cells. The results show dihydrolipoic acid oxidation correlates with cytotoxicity and prooxidant action, allowing prediction of compound
Protein and-peptide-drug-delivery-systemsGaurav Kr
The document discusses protein and peptide drug delivery systems. It begins by defining proteins and peptides, noting that proteins are molecules composed of over 50 amino acids, while peptides are molecules composed of less than 50 amino acids. It then discusses how scientific advances in molecular and cell biology have led to the development of recombinant DNA and hybridoma technology to produce protein products. The document provides examples of marketed protein and peptide drugs and discusses challenges with delivering these drugs orally due to their large molecular size and susceptibility to enzymatic degradation. It explores approaches to protein and peptide delivery including non-parenteral systemic delivery methods and various considerations for developing delivery systems for these pharmaceuticals.
This document summarizes a seminar presentation on fermentation. It discusses the history of fermentation, types of fermentation including aerobic and anaerobic, types of fermentors/bioreactors, and the industrial production of two important antibiotics - penicillin and streptomycin. For penicillin production, it describes the fermentation process including inoculum preparation, production medium, fermentation conditions, and recovery/purification. For streptomycin, it discusses the producing organism, industrial production process involving inoculum, medium, fermentation phases and conditions, and harvest/recovery methods.
This document provides an overview of phytosomes, which are novel drug delivery systems that combine hydrophilic plant extracts with phospholipids. Some key points:
- Phytosomes have enhanced bioavailability compared to simple herbal extracts as they can better cross lipid membranes and reach circulation.
- They are prepared using solvent evaporation methods, forming chemical bonds between phospholipids and phytoconstituents.
- Popular herbal extracts made into phytosomes include milk thistle, grape seed, green tea, and curcumin, to improve absorption and effects.
- Marketed phytosome products provide hepatoprotection, antioxidant, anti-aging, brain protection, and other benefits, demonstrating their
Pharma supplements recombinant proteins as excipients Stephen Berezenko
1) The document discusses challenges in formulating biotherapeutics like proteins and how commonly used excipients like gelatin and human serum albumin have issues related to purity, consistency, and potential risk of transmitting diseases.
2) It describes how recombinant DNA technology has been used to produce recombinant versions of gelatin and human serum albumin as excipients that are highly pure, consistent, and avoid risks from animal or human sources.
3) Recombinant human albumin called Recombumin has been commercially developed and clinically tested as a safer alternative to use in biotherapeutic formulations compared to traditional excipients from animal or human sources.
This document describes a study that synthesized novel 2,3-dihydro-1H-inden-1-one chalcone-like compounds and their hydroxyl derivatives to evaluate their inhibitory effects on mushroom tyrosinase activity. Two compounds, 2a and 2b, inhibited tyrosinase's diphenolase activity in a dose-dependent manner, with IC50 values lower than the positive control, kojic acid. Kinetic analysis showed that compounds 2a and 2b are reversible competitive inhibitors of tyrosinase. Compound 2b, with a 3,4-dihydroxy group resembling the substrate L-DOPA, exhibited the most potent inhibition, suggesting hydroxy-substituted 2,
Site specific targeting: chemical modifiction of structureManali Parab
Chemical modification can be used for site specific targeting of drugs. This involves introducing metabolically sensitive moieties into drug molecules to control their metabolism and deactivation after producing therapeutic effects. Two key approaches are soft drugs, which are designed to rapidly metabolize into inactive species, and chemical delivery systems (CDS), which use sequential enzymatic conversions to differentially distribute drugs. Computer-aided drug design can help optimize properties like binding affinity, absorption, and pharmacokinetics to aid in developing targeted drugs.
Evaluation of the Glucuronic Acid Production and Other Biological Activities...IJMER
The document evaluates the production of glucuronic acid and other biological activities of fermented sweetened black tea fermented with Kombucha culture alone or in combination with different Lactobacillus strains isolated from Kefir grains. Key findings include:
1) Lactobacillus casei increased glucuronic acid production in fermented tea by 39.6% compared to Kombucha culture alone.
2) Lactobacillus plantarum enhanced the antibacterial and antioxidant activities of fermented tea to a greater level than normal fermented tea or mixes with other Lactobacillus strains.
3) The study suggests certain Lactobacillus strains from Kefir grains
The document discusses biotransformation, which is the biological process by which organic compounds are modified by enzymes in microbial, plant, and animal cells. Microbial transformation is preferred over plant or animal cell transformation due to microbes having a higher surface-to-volume ratio, growth rate, and metabolism rate, as well as being easier to maintain sterility. Microbial transformations can occur under mild conditions and achieve high yields, regioselectivity, stereoselectivity, and multi-step conversions using different microorganisms.
Abraham Maslow nació en Brooklyn y tuvo una infancia solitaria. Estudió psicología y desarrolló la teoría de la jerarquía de necesidades humanas, que describe cómo las personas satisfacen necesidades fisiológicas, de seguridad, sociales, de estima y de autorrealización. Su teoría influyó en el pensamiento humanista y propuso que las personas buscan constantemente desarrollar su máximo potencial.
Powerpoint demo for emaze's Automatic DesignMotti Nisani
A business plan (BP) describes an organization's current status and forecasts growth over the next quarter to several years. An effective BP should focus on strategic plans related to timelines for goals, resource allocation, analyzing strengths/weaknesses versus competition, and employee communication. A simple BP can be more effective by focusing on concise information presented clearly, as simplicity is often best. The plan should attract and inform readers with clear and simple rules and data.
El documento describe el diseño de un entorno virtual para la autoformación (EVFA) para profesionales de la educación en la Región de Murcia. El EVFA se basa en la plataforma Claroline y permitirá la autoformación continua a través de diversas herramientas como foros, wikis y mensajería. El EVFA seguirá un modelo constructivista con actividades como bienvenida, desarrollo, reflexión y evaluación.
Crisis on line y monitoreo en redes socialesCarlos Flores
Este documento ofrece consejos para enfrentar crisis en redes sociales y monitorear la reputación en línea. Recomienda analizar la intensidad del impacto de la crítica, su influencia y dispersión para determinar cómo responder, ya sea no responder, hacerlo de manera personalizada o emitir un comunicado. También sugiere identificar voceros, cómo los usuarios encuentran a la empresa en internet, monitorear a la competencia y hashtags usados para hacer tendencias de manera coordinada.
The document describes a picture showing one goldfish in a bowl on the left and four goldfish in a bowl on the right. The lonely goldfish in the left bowl calculated how to maximize its chances of survival by leaping into the fuller bowl with other goldfish, despite the risk of death, in order to avoid being alone. After meticulous planning, the goldfish was ready to take the leap.
El documento proporciona instrucciones para un estudiante llamado David Alexander bustos Guevara para guardar una página web con un color de fondo específico y márgenes, y comprobar que funciona correctamente en un navegador.
SMART goals are specific, measurable, attainable, realistic, and timely. To set a specific goal, you must answer the six "W" questions: who, what, where, when, which, and why. Measurable goals allow you to track your progress. Realistic goals should represent an objective you are willing and able to work towards. Time-bound goals provide a sense of urgency to work on accomplishing the goal.
The document discusses and compares two remote cultures - a tribe in South America and a family from West Virginia. Both cultures lack resources and contact with outsiders that would allow them to advance. While the family in West Virginia had more advances, the South American tribe is nomadic. The cultures are similar in that they do not interact with people unlike themselves. They were created by people who were happy with their ways of living and do not know other options. Teaching them modern ways would be difficult as they are used to their current lives and happy as is, so the document argues it is best not to interfere.
The document describes a proposed mobility aid called the eWGO for individuals with partial mobility. It is intended to be lightweight, portable, foldable, and comfortable to use across different terrains while allowing independent movement and use of public transportation. The client, Gus Alexiou, has multiple sclerosis and requires a seated mobility aid that is lightweight and easily portable for use on public transportation to avoid expensive taxi rides.
DOI:10.21276/ijlssr.2016.2.4.23
ABSTRACT- Atorvastatin calcium is a HMG-CoA reductase inhibitor used for the treatment of hyperlipidaemia. It has
oral bioavailability of ≤12 %. It also undergoes high first pass metabolism. It is highly soluble in acidic pH and absorbed
more in the upper part of the gastrointestinal tract. In order, to improve the absorption and its oral bioavailability,
niosomes of Atorvastatin calcium have been formulated and evaluated on different parameters. Four niosomes
formulations of Atorvastatin calcium were successfully developed by modified ether injection technique using nonionic
surfactant i.e. Span 20, Span 40, Tween 20, Tween 40 and cholesterol at different concentrations. Key-words- Atorvastatin calcium, Niosomes, Surfactants, Cholesterol, Modified ether injection method, in-vitro release,
Stability studies
This document describes research into developing a smart pH-responsive hydrogel for controlled delivery of the anticancer drug capecitabine. The researchers synthesized a hydrogel network using hydroxypropyl-β-cyclodextrin, agarose, and methacrylic acid via free radical polymerization. The capecitabine-loaded hydrogels were characterized and found to efficiently load and release the drug in a pH-responsive manner. Acute oral toxicity tests in animals found the hydrogel to have a good safety profile with no signs of toxicity. The findings indicate the developed hydrogel shows potential as a controlled delivery system for anticancer agents.
folic acid chitosan conjugate nanoparticle containing azithromycin for the tr...shivamgupta1083
The document presents a research proposal for developing folic acid-chitosan conjugate nanoparticles containing azithromycin for treating colorectal diseases. The objectives are to prepare drug-loaded conjugates with desired release characteristics and assess their targeting efficacy and bio-distribution. The plan involves preformulation studies, preparing the folic acid-chitosan conjugate, loading the conjugate with azithromycin, and characterizing the nanoparticles. In vitro and in vivo studies will evaluate particle properties, drug release, cytotoxicity, and the ability to treat colorectal inflammation in a rat model.
The document presents a kinetic model for the acid-catalyzed delignification of sugarcane bagasse by aqueous acetic acid (AcH). The model introduces the concept of "potential degree of delignification (dD)" to account for the multilayered structure of plant cell walls and the inhibitory effect of dissolved lignin. Experimental results showed that delignification rate followed first-order kinetics with respect to sulfuric acid concentration but had a high reaction order with respect to AcH concentration. The activation energy for delignification was determined to be 64.41 kJ/mol. Mechanism analysis found that cleavage of α-aryl ether bonds in lignin was mainly responsible for lignin fragment formation, and increasing AcH
This document summarizes a presentation on protein and peptide drug delivery systems. It discusses the importance of pre-formulation and formulation considerations for proteins and peptides, including toxicity, immunogenicity, and stability from regulatory perspectives. The key points covered include the definition of proteins and peptides, common formulation excipients to prevent denaturation like serum albumin and amino acids, and analytical techniques used for characterization like UV spectroscopy, electrophoresis and liquid chromatography. Maximizing oral absorption through chemical modifications like hydrophobization is also summarized.
Research by Mahendra Kumar Trivedi - Evaluation of the Impact of Biofield Tre...john henrry
Research on Trivedi Effect - In the present study, the influence of biofield treatment on physical and thermal properties of Casein Enzyme Hydrolysate (CEH) and Casein Yeast Peptone (CYP) were investigated. The control and treated samples were characterized by Fourier transform infrared (FT-IR) spectroscopy, differential scanning calorimetry (DSC), Thermo Gravimetric Analysis (TGA), particle size and surface area analysis.to read more visit http://www.academicroom.com/article/evaluation-impact-biofield-treatment-physical-and-thermal-properties-casein-enzyme-hydrolysate-and-casein-yeas-t-peptone
Research by Mahendra Kumar Trivedi - Evaluation of the Impact of Biofield Tre...Abby Keif
http://works.bepress.com/mahendra_trivedi/54/ - Research on Trivedi Effect - In the present study, the influence of biofield treatment on physical and thermal properties of Casein Enzyme Hydrolysate (CEH) and Casein Yeast Peptone (CYP) were investigated. The control and treated samples were characterized by Fourier transform infrared (FT-IR) spectroscopy, differential scanning calorimetry (DSC), Thermo Gravimetric Analysis (TGA), particle size and surface area analysis.
This document summarizes a study that developed and optimized chitosan-alginate nanoparticles for oral delivery of the drug rosuvastatin calcium. The nanoparticles were prepared using ionotropic gelation and characterized for properties such as size, surface charge, drug loading efficiency, and in vitro drug release. The optimized nanoparticles had an average size of 349.3 nm, a zeta potential of +29.1 mV, high drug loading and entrapment efficiencies, and showed a fast initial release followed by more gradual release over 24 hours. The study demonstrated that the chitosan-alginate nanoparticle system improved rosuvastatin solubility and has potential to enhance its oral bioavailability and therapeutic efficacy.
The effect of conjugation on different polymers in bioadhesive films of losartanSriramNagarajan18
The document summarizes a study that investigated the effect of conjugating different polymers on the properties of buccal films containing the drug losartan potassium. Sodium alginate and chitosan were conjugated with cysteine and thioglycolic acid respectively, and films containing plain or conjugated polymers were prepared and evaluated. The conjugation was confirmed using FTIR and the polymers were found to contain thiol groups. Films were evaluated for properties like thickness, drug content, swelling, bioadhesion and drug permeation. Formulations containing conjugated polymers showed higher bioadhesion, swelling and longer drug permeation compared to films with plain polymers. The optimized formulations were found to be stable.
This document discusses various techniques for enhancing the bioavailability of drug formulations, including cocrystallization, copolymerization, and PEGylation. Cocrystallization involves forming a crystalline complex between an active pharmaceutical ingredient and a co-crystal former, which can improve solubility and bioavailability. Copolymerization uses block copolymer micelles to encapsulate hydrophobic drugs and improve their solubility. PEGylation attaches polyethylene glycol chains to proteins and peptides to increase their circulating half-life and protect them from degradation. The document examines each technique in more detail and concludes that proper selection of a bioavailability enhancement method is key to developing an effective drug formulation.
Introduction,Drug- Excipient Compatibility Experimental Design ,Excipient role in drug destabilization,DRUG EXCIPIENT COMPATIBILTY IN PARENTERAL PRODUCTS.This topic are described.
This study assessed the enzymatic hydrolysis of proteins from the microalgae Chlorella pyrenoidosa and Spirulina sp. LEB 18 to produce protein hydrolysates. Three commercial proteases were used under different conditions to hydrolyze the microalgae proteins. The highest degrees of hydrolysis for Spirulina and Chlorella, respectively, were 55.31% and 52.9% and were obtained with 4 hours of reaction time using Protemax N200 protease. Statistical analysis showed that enzyme concentration, substrate concentration, and reaction time significantly affected the degree of hydrolysis. The results indicate it is possible to obtain protein hydrolysates with varying degrees of hydrolysis from microalgae
This document provides a synopsis for a Master's thesis project titled "Formulation and Evaluation of Fast Dissolving Films of Lisinopril". The project aims to develop fast dissolving films of the hypertension drug Lisinopril to improve patient compliance. Literature on fast dissolving drug delivery systems and films has been reviewed. The planned work involves preparing Lisinopril films using natural and synthetic polymers through various techniques and evaluating the films for properties like drug content, dissolution, and pharmacodynamics. If successful, the fast dissolving Lisinopril films could provide quick action and ease of administration benefits for hypertension patients.
JBEI Research Highlights - October 2018 Irina Silva
This document discusses three approaches:
1) Engineering E. coli to modulate membrane lipid composition and control cellular respiration through changes in inner membrane viscosity.
2) Applying synthetic biology tools like promoter engineering and metabolic pathway construction to investigate fundamental biochemical questions that cannot be easily studied otherwise.
3) Outlining the background, approach, and outcomes of using E. coli to produce renewable jet fuel precursors like sesquiterpenes from isoprenoid pathways.
1) The document describes research into using "nanosponges" and hydrogels as drug delivery vehicles to improve the oral bioavailability of drugs that have low absorption in the gastrointestinal tract.
2) The researchers encapsulated the chemotherapy drug paclitaxel into polycarbonate-based nanosponges and hydrogels. In vitro tests showed the vehicles protected the drug and released it slowly over time.
3) Future work involves testing the drug release properties under simulated gastric conditions and analyzing intestinal uptake of nanosponges functionalized with a peptide to target the intestinal peptide transporter PepT1.
Conceição et al, 2009. characterization of a new bioactive peptide from potam...pryloock
This document describes the characterization of a novel bioactive peptide, named Porflan, purified from the venom glands of the freshwater stingray Potamotrygon gr. orbignyi. Porflan has the primary structure ESIVRPPPVEAKVEETPE and showed no similarity to known proteins or peptides. Two synthetic analogs of Porflan, named Porflan-N and Porflan-C, were also generated. Porflan was found to increase the number of leukocyte rolling in microcirculatory assays. Molecular dynamics simulations provided insights into Porflan's interactions with membrane phospholipids. This study identifies a new class of bioactive peptides in fish venom involved in inflammatory processes
The document summarizes a presentation on antioxidant peptides derived from the blue-spotted stingray. It discusses alternative methods to obtain bioactive peptides from proteins, characterization of antioxidant capacity, identification of two antioxidant peptides (WAFAPA and MYPGLA) from the <3 kDa fraction of stingray hydrolysate, and characterization of their stability under thermal, pH, and simulated digestion conditions. The conclusion discusses the potential of antioxidant peptides for food and medical applications and need for further research.
Bioavailability and methods of enhancing bioavailabilityMohammed Yousuf
The document discusses various methods for enhancing bioavailability of drugs. It begins by outlining common causes of low bioavailability such as first-pass metabolism and poor solubility. It then describes several methods for improving bioavailability including increasing drug solubility through techniques like micronization and use of surfactants, and enhancing permeability through lipid technologies and penetration enhancers. Specific technologies are also discussed like Optizorb which uses super-disintegrants to speed absorption and hot-melt extrusion which molecularly disperses drugs to increase dissolution. Nanoparticle systems are also proposed to increase permeability through physiological barriers like the blood-brain barrier to potentially treat diseases like Alzheimer's and Parkinson's.
Bioequivalence Study of the Two Products of Efavirenz by Validated Analytical...BRNSS Publication Hub
The aim of this study was to find whether the bioavailability of a 600 mg efavirenz capsule (E.F.600 capsule, test) produced by Macneil and Argus Pharmaceutical Ltd. was equivalent to the tablet EFAVIR produced by the Cipla Ltd. (reference preparation). The pharmacokinetic parameters assessed in this study were area under the plasma –concentration time curve 0–96 h (AUCt), area under the plasma concentration time curve from time 0 to ∞ (AUCinf), the peak plasma concentration of drug (Cmax), time needed to achieve the peak plasma concentration (tmax), and the elimination half-life (t½). This was a randomized, single-blind, two-period, crossover study which included 20 healthy adult male and female subjects under fasting conditions. In each of the two study periods (separated by a washout of 1 week), single dose of test or reference drug was administered. Blood samples were taken up to 96 h past dose, the plasma was separated, and the concentrations of efavirenz were determined by high-performance liquid chromatography -UV method. Bioavailability and bioequivalence studies play a key role during the phase of drug development for both innovator drugs and generic drugs and thus have gained a great attention over the past few decades. Bioequivalence study is used to introduce generic drugs of innovator drugs at a lower cost. Hence, a thorough understanding of these bioavailability/bioequivalence studies is required.
The document describes the synthesis and evaluation of nitromethane substituted chalcone derivatives for their antimicrobial and antitubercular activity. Chalcones were synthesized from substituted acetophenones and aldehydes under basic conditions. Michael adducts were obtained by reacting the chalcones with nitromethane under Michael addition reaction conditions. The structures of the compounds were characterized using NMR and IR spectroscopy. Docking studies were performed to study the binding interactions of the compounds with various Mycobacterium tuberculosis protein targets. The compounds were evaluated for their in vitro antitubercular, anthelmintic and antimicrobial activity. Some compounds showed good activity against Mycobacterium tuberculosis and against various microorgan
Similar to In vitro and in vivo evaluation of positively charged liposaccharide derivatives as oral absorpti (20)
In vitro and in vivo evaluation of positively charged liposaccharide derivatives as oral absorpti
1. ForPeerReview
In vitro and in vivo evaluation of positively charged
liposaccharide derivatives as oral absorption enhancers for
the delivery of anionic drugs
Journal: Journal of Pharmaceutical Sciences
Manuscript ID: 09-326
Wiley - Manuscript type: Research Article
Date Submitted by the
Author:
22-May-2009
Complete List of Authors: Bergeon, Julie; The University of Queensland, School of Chemistry
and Molecular Biosciences
Ziora, Zita; The University of Queensland, Centre for Integrated
Preclinical Drug Development (CIPDD)
Abdelrahim, Adel; The University of Queensland, School of
Chemistry and Molecular Biosciences
Pernevi, Niklas; The University of Queensland, School of Chemistry
and Molecular Biosciences
Moss, Anne; The University of Queensland, School of Chemistry and
Molecular Biosciences
Toth, Istvan; The University of Queensland, Centre for Integrated
Preclinical Drug Development (CIPDD); The University of
Queensland, School of Chemistry and Molecular Biosciences
Keywords:
Oral drug delivery, Absorption enhancer, Bioavailability, Caco-2
cells, Calorimetry (ITC), Pharmacokinetics/pharmacodynamics,
Cationic lipids
John Wiley & Sons, Inc.
Journal of Pharmaceutical Sciences
2. ForPeerReview
In vitro and in vivo evaluation of positively charged liposaccharide derivatives as oral absorption
enhancers for the delivery of anionic drugs
Julie A. Bergeon1
, Zyta M. Ziora2
, Adel S. Abdelrahim1
, Niklas U. Pernevi, Anne R. Moss1
, Istvan Toth1,2
1
The University of Queensland, School of Chemistry and Molecular Biosciences, Brisbane, Qld 4072,
Australia
2
The University of Queensland, Centre for Integrated Preclinical Drug Development (CIPDD),
Brisbane, Qld 4072, Australia
Keywords: charged liposaccharide, ion-pairing, Caco-2 cells, calorimetry (ITC), absorption enhancer,
piperacillin, oral drug delivery, bioavailability
ABSTRACT
Oral delivery of hydrophilic, ionisable drugs remains a major challenge in drug development and a
number of active pharmaceuticals fail to reach the market of oral drugs because of a lack of
absorption and/or stability issues. One possible approach to improving the bioavailability of such
drug candidates is to increase their lipophilicity, which is a key parameter in the permeation across
cell membranes. However, modifying the chemical structure of an active compound by adding lipid
residues often results in changes in activity. With ionised molecules, ion-pairing can be considered to
associate charged lipid moieties with the parent drug without altering its structure and therefore
activity. This study presents the results of in vitro and in vivo evaluation of a series of positively
charged liposaccharide derivatives combined with an anionic model drug, piperacillin. The
antimicrobial activity, plasma stability, permeability in Caco-2 cell monolayers and oral absorption of
the synthesised conjugates were assessed.
INTRODUCTION
Recent advances in drug development have shown the crucial need for developing new active drugs
to treat and/or prevent diseases which currently resist conventional therapies.
However, the promising therapeutical profiles of a large number of potential drug candidates
(including ionic/ionisable molecules, peptides and protein-like pharmaceuticals with a high
hydrophilic character) is often dampened by issues such as low oral bioavailability and poor in situ
stability.1,2
To overcome these difficulties, different strategies such as structural modifications by
adjunction of various protecting groups to improve stability, or use of surfactants and absorption
enhancers to increase membrane permeability, essentially by passive diffusion, have been
investigated. 3,4
Considering the lipidic nature of the bilayered cell membrane, the derivatisation of
drugs by lipidation has been extensively investigated and improvements in enzymatic stability and
membrane permeability have been reported. 5,6
Although increased lipophilicity can facilitate
absorption across membranes, it is also frequently associated with solubility difficulties in aqueous
media.
Another approach to overcome absorption problems revolves around the ionizability of polar
molecules. Hydrophilic drugs are commonly commercialised as salts (e.g. sodium, acetate, chloride
salts), more soluble and often more stable7
than the parent molecule, which means that the drug
itself can potentially exhibit charges depending on pH conditions (both in solution and in situ). This
offers ample possibilities to associate lipophilic counter-ionic moieties by ion-pairing in order to
enhance the overall lipophilicity of these hydrophilic drugs while preserving their biologically active
chemical structure. 8
Page 1 of 20
John Wiley & Sons, Inc.
Journal of Pharmaceutical Sciences
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
3. ForPeerReview
In an earlier study, we reported that the in vitro permeability of piperacillin across Caco-2
monolayers could be notably improved by associating this anionic β-lactam antibiotic to a positively
charged liposaccharide containing a D-glucose moiety coupled to a twelve-carbon long lipoamino
acid (α-amino acid with lipophilic alkyl side-chain). 9
Positive results were also observed when
varying the lipid chain length. Lipoamino acids (LAAs) are versatile molecules with the unique ability
to be linked through either their amino or carboxyl extremities. They can be readily obtained from
alkyl bromide precursors in a few, short and easy synthetic steps. Lipoamino acids combined with
carbohydrates offer several advantages versus lipids alone. Firstly, it allows for a modulation of the
degree of lipophilicity brought by the lipid chain via the hydroxyl residues present on the
carbohydrate moiety, hence preserving the water solubility characteristics of the modified drug
while still increasing its lipophilicity. Secondly, sugars can be selected to interact with specific
membrane receptors where available, offering the possibility of a mediated transport across
membranes as an alternative to passive diffusion.
The amine function of the lipoamino acids is subject to acido-basic equilibrium and therefore is not
constantly protonated, which can be problematic as this residual charge is the key element of the
interaction between the drugs of interest and counter ionic liposaccharides. Quaternization of the
terminal amine was therefore considered to create a constantly, positively charged residue. Also, as
the sugar moiety introduced a significant degree of hydrophilicity, additional lipophilic components
were considered in the design of new charged liposaccharides for a better, adjustable balance of
lipophilicity versus hydrophilicity.
MATERIALS AND METHODS
1. Chemistry and analytical characterisation
All solvents and reagents were obtained at the highest available purity from Sigma–Aldrich (Castle
Hill, NSW, Australia) and used directly without further purification. The liposaccharide derivatives
presented in this publication were prepared according to the methodology described by Abdelrahim
et al. 10
. Commercially available piperacillin sodium was converted into piperacillin acid using an IR-
120-[H+
] cationic exchange resin (Rohm Haas, Philadelphia, PA, USA). The salt was dissolved in water
and vigorously stirred with the resin for 30 mins, until pH stabilised at 3 and piperacillin acid
precipitated. The precipitate was then dissolved in acetonitrile and the resin was filtered off, washed
with acetonitrile, and the filtrate was then lyophilised on an Alpha 2-4/LSC (Martin Chris, Osterode
am Harz, Germany) at -80°C, < 150 psi. Two methodologies for lyophilisation were used; (i) with
piperacillin sodium, the liposaccharide derivatives were mixed with the commercial salt and
dissolved in pure glacial acetic acid; the excess acid was removed under vacuo and the mixture was
then lyophilised; (ii) with piperacillin acid, the liposaccharide derivatives and the drug were dissolved
in water/acetonitrile (1:1) and lyophilised.
ESI-MS and MS/MS analyses were carried out on a PE Sciex API3000 triple quadrupole mass
spectrometer, using a mixture of solvent A (1% formic acid in water) and B (1% formic acid in 9:1
acetonitrile/water) at 0.1 mL/min. For LC–MS/MS experiments, a Phenomenex luna C18 column (5
µm, 50 mm × 2.0 mm) equipped with a C18 guard column (4 × 3.0 mm) was attached to the mass
spectrometer and a 30-100% gradient of B in A over 4 minutes was used for elution at a flow rate of
0.5 mL/min with a 1:10 splitter upstream from the ionisation source (Shimadzu LC-10AT system). 9
Data were acquired with Analyst 1.4 software (Applied Biosystems/ MDS Sciex, Toronto, Canada).
2. Isothermal Titration Microcalorimetry (ITC)
ITC measurements were performed on a MicroCal VP-ITC microcalorimeter (Northampton, MA,
USA), with Origin 5.0 and VP viewer 2000 software. Experiments were performed at 37°C in purified
water (MiiliQ Gradient A10, Millipore, North Ryde, NSW, Australia) with degassed, sonicated
Page 2 of 20
John Wiley & Sons, Inc.
Journal of Pharmaceutical Sciences
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
4. ForPeerReview
samples. The reference cell was loaded with water while the sample cell (1.4395 mL) was charged
with piperacillin acid (0.05 – 0.5 mM) and rotated at 300 rpm. The liposaccharide derivatives (4 mM)
were injected into the sample cell using a microsyringe at a rate of 3-10 µL every 6 minutes (total
injection volume 300 µL).
3. Antimicrobial assays (MIC)
MIC experiments were carried using a broth dilution method. Two strains of bacteria were used,
Escherichia coli (MC4100) and Pseudomonas aeruginosa (A01). Bacteria were cultured in Luria-
Bertani (LB) broth medium (1% w/v NaCl, 1% w/v tryptone, 0.5% w/v yeast extract, adjusted to pH 7
and autoclaved at 121°C for 20 minutes before use; reagents purchased from Sigma-Aldrich, Castle
Hill, NSW, Australia). Bacterial growth was monitored by optical density (OD) measurements,
performed on an Ultrospec 2000 (Pharmacia Biotech, Uppsala, Sweden). Bacteria were grown to an
OD ≥ 1 then diluted with LB broth and sub-cultured again to reach an OD of 0.3-0.8. They were then
diluted to a count of 1 × 106
cfu / 100 µL (OD 0.1) and plated in 96-well round bottom plates (TPP,
Zurich, Switzerland).
Lyophilised preparations of piperacillin and liposaccharides were dissolved in 5% dimethylsulfoxide
(DMSO)/water and serially diluted (1:3) with LB broth to reach a final piperacillin concentration of 0-
25 mM for E. coli and 0-52 mM for P. aeruginosa. The bacteria (100 µL) were then mixed with the
drug solutions (100 µL) and incubated for 16-20 hrs at 37°C, after which bacterial growth was
assessed by OD measurements at 600 nm on a Spectramax 250 plate reader (Molecular Devices,
Sunnyvale, CA, USA). The MICs for each formulation was then determined by plotting the OD values
vs piperacillin concentrations.
4. Haemolytic assays
Haemolytic assays were undertaken with approval from the University of Queensland Ethics
Committee (approval # 2006000950). Full venous blood samples were taken from healthy adult
volunteers. Red blood cells (hRBCs) were isolated from the whole blood by centrifugation at 2576 G
for 15 min (Sigma 2-5 centrifuge, Sigma Laborzentrifugen GmbH, Osterode am Harz, Germany).
Plasma was removed and the cells were washed several times with PBS before being resuspended in
PBS (to original blood volume) and aliquoted (100 µL) in 96-well flat bottom plates (TPP, Zurich,
Switzerland).
Solutions of the tested compounds were prepared in PBS (0.2 – 20 µM) and dispensed in the wells
containing the hRBCs preparations. The plates were then incubated at 37°C for 60 mins on a
Heidolph ShakingIncubator & Titramax 1000 (Schwabach, Germany) at 400 rpm, after which they
were centrifuged at 2129 G for 15 min; 75 µL of the supernatant was then removed and placed into
new plates before absorbance was measured at 540 nm using a Spectramax 250 microplate reader.
PBS was used as a negative control; water and SDS were used as positive controls. The percentage of
haemolysis caused by each of the tested formulation was calculated by the following equation:
where min A540 represents the absorbance at 540 nm of PBS alone, and max A540 represents the
absorbance at 540 nm of SDS.
5. Caco-2 permeability assay
Cell culture reagents were purchased from Gibco-BRL (Grand Island, NY, USA) except of Hank’s
balanced saline solution (HBSS) and 14
C-labelled mannitol which were supplied by Sigma–Aldrich
(Castle Hill, NSW, Australia) and Amersham Biosciences (Piscataway, NJ, USA), respectively. Tissue
culture flasks (75 cm2
) were obtained from BD Bioscience (Franklin Lakes, NJ, USA).
Page 3 of 20
John Wiley & Sons, Inc.
Journal of Pharmaceutical Sciences
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
5. ForPeerReview
Caco-2 cells from the American type culture collection (Rockville, MD, USA) were maintained in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% foetal bovine serum (FBS),
and 1% nonessential amino acids at 95% humidity and 37°C in an atmosphere of 5% CO2. The
medium was changed every second day. After reaching 80% confluence, the cells were subcultured
using 0.2% ethylenediaminetetraacetic acid (EDTA) and 0.25% trypsin. 100 µL of a solution
containing approx. 106
cells/mL (passage number 31-40) were seeded onto polycarbonate
Transwell® inserts supplied by Coastar (Cambridge, MA, USA; mean pore size = 0.45 µm, 6.5 mm
diameter) and cultivated in DMEM supplemented with 10% FBS, 1% non-essential amino acids, 100
U/mL penicillin and 100 mg/mL streptomycin. The cells were allowed to grow for 21–28 days and the
medium was changed every other day.
The tested compounds were dissolved in HBSS–HEPES (HBSS buffered with 25 mM 4-(2-
hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES) at pH 7.4) to a final concentration of 200 µM.
Prior to the transport studies, the Caco-2 monolayers were washed three times with pre-warmed
HBSS–HEPES and the integrity of the monolayers was assessed by measuring the TEER values using a
Millicell-ERS system (Millipore Corp., Bedford, MA, USA); TEER were also measured after each
experiment. Typical values were in the range 0.8-1.6 kΩ.cm2
. The drug solutions (100 µL) were added
to the donor side of the monolayers and the Transwell® plates were placed in a shaking incubator
set to 400 rpm and 37°C for the duration of the experiment. At pre-determined time points (30, 90,
120 and 150 min), samples (400 µL) were taken from the receiver chamber and replaced with the
same amount of HBSS–HEPES. All compounds were tested in two to three independent assays, using
four wells each time. Concentrations in piperacillin were determined by LC–MS/MS. The transport of
14
C-mannitol (200 µM), a marker of paracellular transport, was also measured in parallel. After
dilution of samples (400 µL) with 4 mL of Wallac OptiPhase HiSafe 3 liquid scintillation cocktail
(Montreal, Canada), radioactivity was measured using a Beckman Coulter LS650 Multipurpose liquid
scintillation spectrometer (Beckman Instruments, Fullerton, CA) and permeability values determined
by the following equation:
where dC/dt is the steady-state rate of change in the chemical in the receiver chamber (mM, or dpm
mL-1
), Vr is the volume of the receiver chamber (mL), A is the surface area of the cell monolayers
(cm2
) and C0 is the initial concentration in the donor chamber (mM, or dpm.mL-1
).
6. Oral absorption studies
Animal studies were undertaken with approval from the University of Queensland Ethics Committee
(approval #SMMS/002/08/ARC). 8-week old male Sprague Dawley rats (300-350g, 4 rats/compound)
were administered formulations of the tested compounds in 5% DMSO/water by oral gavage, to a
level of 50 mg/kg of piperacillin for each rat. At regular time points (0, 5, 10, 15, 30, 60, 90, 120
minutes), blood samples (200 µL) were collected in heparinised tubes by tail vein bleeding. The rats
were euthanized immediately after the experiment by inhalation of a 1:1 O2/CO2 mixture; death was
further asserted by cervical dislocation.
Blood samples were centrifuged for 20 min at 1717 g and the plasma was collected, treated with
acetonitrile (1:1 v/v) to precipitate the proteins and centrifuged. The supernatant was then collected
for analyses by LC-MS/MS (or kept at -30°C if analyses could not be run immediately).
7. Statistical analysis
Results were expressed as mean values ± standard error mean (SEM). Where applicable, statistical
analysis of values was performed by one-way analysis of variance (ANOVA) of repeated measures to
a significance level of 0.05 (p < 0.05), followed by Tukey’s post hoc test (multiple pairwise
Page 4 of 20
John Wiley & Sons, Inc.
Journal of Pharmaceutical Sciences
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
6. ForPeerReview
comparison of means). Computations were realised using GraphPad Prism v5.01 (GraphPad
software, La Jolla, CA, USA).
RESULTS AND DISCUSSION
Design and preparation of a new series of charged liposaccharide derivative carriers
A novel series of liposaccharide derivatives was synthesised by modifying the amino extremity of the
liposaccharide. The resulting compounds comprised a D-glucose (G) moiety and a twelve carbon long
LAA (C12) scaffold, onto which additional amino residues, namely leucine, phenylalanine (two of the
most hydrophobic amino acids) 11
and another C12 were attached. The N-terminus amino group was
then converted into a quaternary ammonium salt using Amberlite 400 [HO-
] as a base 10
and the
obtained liposaccharide derivatives were lyophilised together with the model drug piperacillin (Fig.
1).
Fig. 1 – Synthesised charged liposaccharide derivatives associated with model drug piperacillin
Initially, lyophilisation was attempted directly with the commercially available piperacillin sodium
salt under acidic conditions (glacial acetic acid); however, preliminary observations (binding studies
and nuclear magnetic resonance analyses, results not shown) suggested that limited interactions
occurred between the anionic drug and its cationic liposaccharide counterparts. It is believed that
this could be due to strong ionic binding between the piperacillin anion and the sodium cation,
which is smaller and has a greater charge density compared to the charged liposaccharide
derivatives (calculated Hückel charge of 0.788 (GC12C12)); as a consequence, the exchange between
the two cations was likely to be thermodynamically unfavourable. To facilitate this substitution,
piperacillin sodium was dissolved in water and stirred with a cation-exchange resin under controlled
pH to obtain piperacillin acid, which was then immediately lyophilised with different liposaccharide
derivatives from a 1:1 acetonitrile-water solution. The prepared conjugates were stored at -20°C and
their integrity was monitored by analytical examination by 1
H-NMR.
Different ratios of drug/liposaccharide were considered in this study. Initial measurements of
binding by isothermal titration microcalorimetry (ITC) revealed that two concurrent processes were
taking place, binding (ion-pairing) and micellization. A 1:1 ratio did not seem to be sufficient to
observe optimum ionic interactions, possibly due to the presence of multiple interaction sites on the
model drug. Indeed, when examining interactions between piperacillin and GC12C12, a ratio close to
1:2 drug/liposaccharide was found to give optimal ion interactions (Fig. 2). The negative enthalpy
observed initially below a 1:2 ratio is indicative of favourable ion-pairing, while above 1:2, the
process becomes endothermic as a result of micellization occurring. As the ratio of
drug/liposaccharide was increased, the micellization of the lipidic cations was predominantly
observed over the binding process (results not shown) and therefore ion-pairing, if present, could
not be significantly assessed.
Figure 2. Isothermal titration microcalorimetry (ITC) binding assay between piperacillin (acid form,
0.2 mM) and liposaccharide derivative GC12C12 at 4 mM in purified water.
All liposaccharide derivatives were therefore tested in association with piperacillin in a 1:2
drug/counter-ion ratio. A 1:1 ratio was also examined to see if even a lower quantity of
Page 5 of 20
John Wiley & Sons, Inc.
Journal of Pharmaceutical Sciences
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
7. ForPeerReview
liposaccharide derivatives was sufficient to generate an increase in oral absorption (penetration
enhancing effect).
Antimicrobial activity
The antimicrobial activity of the drug conjugates was assessed in vitro in two Gram-negative
bacterial strains, Escherichia coli and Pseudomonas aeruginosa. Minimum inhibitory concentrations
(MICs) were determined by a broth dilution method 12
and compared to the MIC of piperacillin
alone. Previously synthesised 2-amino-N-(2’-α,D-gluco)dodecanamide (GC12) 9
was also tested in the
same 1:1 and 1:2 molar ratios.
After 16-20 hours incubation with bacterial cultures at 37 °C, resistance to piperacillin alone was
found to be in agreement with reference values of 2-4 µg/mL for E. Coli 13
and 3-6 µg/mL for most
strains of P. aeruginosa. 14,15
. When the drug was tested in association with the synthesised charged
liposaccharide derivatives, no significant change was observed in the MIC values for P. aeruginosa,
all averaging 7-12 µg/mL (Fig. 3). For E. coli, slight, however not significant, increases in the MICs
were noticed when piperacillin was formulated with GC12Phe (1:1 and 1:2) and GC12C12 (1:1).
The pairing of the liposaccharide derivatives to piperacillin therefore does not appear to have
negatively impacted the original antimicrobial activity against either bacterial strain. The absence of
significant variation in MICs (verified using a one-way Anova statistical comparison followed by
Tukey’s post-hoc test) when using different ratios of liposaccharides would indicate that the
modified liposaccharides do not have antimicrobial or antagonist properties of their own.
Figure 3. MICs of piperacillin alone and formulated with the synthesised liposaccharide derivatives
for two Gram-negative bacterial strains, E. coli and P. aeruginosa. Concentrations were
determined by optical density measurements at 600 nm after 24 hr incubation in bacterial culture
medium at 37°C. (Values given as mean ± SEM, n≥3)
Haemolytic activity
Although destined to oral drug delivery, the liposaccharide derivatives and their ionic complexes
with piperacillin were nonetheless tested for signs of haemolytic activity, which could cause
disruptions to the biological membranes and yield to toxicity.16,17
Haemolytic activity was assessed in
triplicate against human red blood cells (hRBCs) over 60 minutes at 6 different concentrations,
ranging from 0.1 µM to 10 mM; the tested solutions were formulated in phosphate buffered saline
(PBS) and compared to piperacillin alone. Sodium dodecylsulphate (SDS), a surfactant known to be
toxic to hRBCs at the concentrations used in this assay, was also included as a positive control.
Measurements were done by absorbance readings at 540 nm and the percentage of haemolysis was
determined by the following equation:
Initially, only the synthesised liposaccharide derivatives were considered; one of the complexes, Pip-
GC12C12, was additionally evaluated to examine any possible synergistic effect.
Figure 4. Haemolytic activity measured against hRBCs at 37°C over 1hr of piperacillin (alone and
with GC12C12) and the synthesised liposaccharide derivatives in PBS. The percentage of haemolysis
was calculated by absorbance readings at 540 nm (results given as mean ± SEM, n=3)
Page 6 of 20
John Wiley & Sons, Inc.
Journal of Pharmaceutical Sciences
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
8. ForPeerReview
As shown in Figure 4, the synthetic liposaccharide derivatives expectedly induced haemolysis of
hRBCs to some extent, yet the values remain significantly less than those of SDS in the low
concentration range. Interestingly, the comparison between GC12 and GC12C12 revealed a two-fold
increase on average in haemolytic activity, suggesting a direct correlation between the greater
lipophilicity brought by the second C12 moiety and the haemolytic properties of the liposaccharide.
At commonly used therapeutic concentrations however (i.e. < 1 mM when considering the
standardised intravenous administration of piperacillin sodium), most liposaccharide derivatives
tested showed less than 25 % haemolysis, which is considered to be the threshold for tolerable
toxicity to hRBCs. 18
However, piperacillin in association with GC12C12 in 1:1 and 1:2 ratios yielded
synergistic effects resulting in increased haemolysis, to levels comparable to SDS.
When examining the EC10 (drug concentration causing 10% haemolysis of hRBCs; see Table 1 – the
values were estimated from the graphical data presented in Fig. 4), GC12 and GC12Leu were found to
be moderately haemolytic (0.5 mM < EC10 < 5 mM) while the other two liposaccharide derivatives
GC12Phe and GC12C12 as well as the combined Pip-GC12C12 were classified as strongly haemolytic (0.5
mM < EC10), along with SDS. 17
Table 1. Estimated EC10 of drug, liposaccharide derivatives and combined entities.
These findings are of great importance when considering LAAs as penetration enhancer candidates
for general drug delivery. Although the concentrations used in this assay are far greater than those
used in vivo, the LAA-based molecules tested here showed noticeable signs of toxicity against hRBCs.
In vitro permeability assessment in Caco-2 cells
Prior to conducting oral absorption studies, the in vitro permeability of the synthesised compounds
was assessed in Caco-2 cells. This cell line originates from a human colorectal adenocarcinoma and is
commonly used as a model for predicting the transport of drugs across the intestinal epithelium.
When cultured, Caco-2 cells spontaneously form differentiated, polarised monolayers which express
most structural and functional characteristics of the small intestine, including enzymes and efflux
proteins. Artursson et al. demonstrated that the apparent permeability coefficients determined with
this model can be correlated to human oral drug absorption values with good respect. 19
.
200 µM solutions of piperacillin associated with the different liposaccharide derivatives (1:1 and 1:2
molar ratios) in Hank’s balanced salt solution (HBSS) were added to the apical side of the Caco-2
monolayers and permeability to the basolateral side of the monolayer was studied over 150 min,
using the paracellular marker 14
C-mannitol as a negative control (typical permeability values of 14
C-
mannitol are around 1-5 × 10-7
cm.s-1 19
). Apparent permeability coefficients (Fig. 5) were calculated
from concentrations of piperacillin determined by liquid chromatography coupled to mass
spectrometry (LC-MS/MS) against an 8 point standard curve while 14
C-mannitol was quantified by
liquid scintillation counting (β-emission) 9
.
Piperacillin alone expectedly showed very low permeability across Caco-2 monolayers; the observed
values were higher than reported previously, 3.07(OH)-3.22(Na) × 10-7
cm.s-1
versus 3.24(Na) × 10-8
cm.s-1 9
. A similar 10-fold variation was noticed for Pip-GC12 [1:1] and 14
C-mannitol, this variability
could be explained by the difference in cell passage numbers, since the cells used in the present
study were much younger than in the previous examination. Reports in literature have shown that
the differentiation of the cells was affected by early passage numbers, mainly a lower cohesion of
Page 7 of 20
John Wiley & Sons, Inc.
Journal of Pharmaceutical Sciences
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
9. ForPeerReview
the monolayer and reduced tightness of the paracellular junctions. 20
This was also evidenced by
measurement of transepithelial electrical resistances (TEER), 21
which averaged 0.9-1.1 kΩ in this
study, slightly less than in previous experiments.
As shown in Figure 5, piperacillin demonstrated a marked increase in membrane permeability when
associated in a 1:1 ratio with GC12, which is in agreement with previously reported data. 9
Interestingly, when testing GC12C12 in that same ratio, the increase was slightly less. This could be
correlated to the ITC data which suggest that a 1:1 ratio was not sufficient in the case of GC12C12 to
obtain optimal binding between the parent drug and the charged liposaccharide derivatives. Indeed,
when assessing the drug in a 1:2 ratio with the liposaccharide derivative, the permeability was
greatly enhanced to reach a mean value of 1.27 × 10-5
cm.s-1
, nearly forty times higher than
piperacillin alone. Drugs with apparent permeability coefficients across Caco-2 monolayers of 10-6
cm.s-1
or greater usually present excellent oral bioavailability. 19
; the results obtained in this in vitro
assay therefore suggest that Pip-GC12C12 [1:2] might be a good candidate for oral absorption
evaluation.
Figure 5. Apparent permeability coefficients determined in 21-28 day old monolayers of Caco-2
cells (passage 31-40) over a 150 min period at 37°C (Results given +/- SEM, n=2-3; 4 wells/exp).
The major increase in permeability observed with Pip-GC12C12 [1:2] can also, to a certain extent, be
linked to its toxicity, as evidenced earlier in the haemolytic assay. The measurement of the TEER
values prior to, and after each experiment revealed a drop in resistance across the monolayer, sign
of loss of integrity of the monolayer. It is however unknown whether the loss was permanent or if
the monolayer would recover given time and optimum culture conditions. The other conjugates
tested did not yield to such marked variation in TEER. Surprisingly, the penetration of piperacillin
was not significantly improved when combined with GC12 in a 1:2 molar ratio. No satisfactory ITC
data could be obtained for GC12 so the ratio for optimal binding could not be assessed accurately. It
is also possible that alternative phenomena occurred that could decrease the permeability
enhancing effects of GC12 (e.g. efflux, aggregation, adhesion to membranes). The other
liposaccharide derivatives tested in formulation with piperacillin did not yield significant changes in
permeability, independent of the ratio used.
Oral absorption in rats
Based on the in vitro results and particularly the permeability assays, four of the tested formulations
were evaluated in vivo, namely Pip-GC12 [1:1], Pip-GC12 [1:2], Pip-GC12C12 [1:1] and Pip-GC12C12 [1:2].
Male Sprague-Dawley rats (300-350 g) were administered the formulations by oral gavage; blood
samples were taken from the tail vein over a two hour period and analysed by LC-MS/MS.
Piperacillin given both orally and intravenously (i.v.) was used as a control. The i.v. curve (Fig. 6a)
demonstrates a rapid distribution of piperacillin after injection with mean peak concentration of 70
µg.mL-1
at around 5 minutes. The antibiotic is then rapidly cleared from the circulatory system with
virtually no drug detected after 1h.
The oral uptake of piperacillin was calculated from the AUC120 (mean area under the curve, see Table
2) and was expectedly very low (0.5 %). When examining the absorption of the piperacillin
conjugates, the absorption curves were very similar to that of piperacillin alone, administered orally.
Surprisingly, the improvements in permeability noticed in vitro with the Caco-2 monolayer model
were not observed in vivo, either with GC12 (1:1) or GC12C12 (1:1 and 1:2). The determination of the
AUCs showed 0.14 % to 0.38 % absorption, which statistically is not significantly different from the
0.5 % absorption found for commercial piperacillin sodium (Fig. 6b).
Page 8 of 20
John Wiley & Sons, Inc.
Journal of Pharmaceutical Sciences
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
10. ForPeerReview
Figure 6a. In vivo pharmacokinetics of piperacillin sodium administered intravenously at 50 mg/kg
in saline (0.9 % NaCl) over a 2h period; piperacillin concentration in blood was determined by LC-
MS/MS (Results given +/- SEM, n=3-5).
Figure 6b. In vivo absorption and pharmacokinetics of oral formulations of piperacillin, alone or in
association with liposaccharide derivatives GC12 and GC12C12, in 1:1 and 1:2 ratios in water + 5%
DMSO, over a two hour period. A dose equivalent to 50 mg piperacillin was administered by oral
gavage to 300-350 g Sprague-Dawley rats and piperacillin concentration in blood determined by
LC-MS/MS (Results given +/- SEM, n=3-5).
Table 2. Area Under the Curve (AUC120) values for the in vivo pharmacokinetics profile of
piperacillin alone (oral and i.v.) and in association with liposaccharide derivatives GC12 and GC12C12.
Results are given as mean and relative values against intravenous piperacillin levels.
The literature abounds in reports correlating in vitro predictions of permeability obtained with the
Caco-2 model of intestinal epithelium and in vivo oral absorption. The variations observed in these
experiments are therefore more likely to be inherent to the nature of the compounds tested, as it
appears that piperacillin was most probably released from the liposaccharide derivatives post-
administration.
CONCLUSION
We report here the biological evaluation of a novel series of ionic liposaccharide derivatives
designed as potential oral penetration enhancers. The synthetic constructs were engineered to
combine in a single molecular entity a carbohydrate-based hydrophilic moiety coupled to lipophilic
residues, such as hydrophobic amino acids and twelve carbon long LAAs. Piperacillin, a potent β-
lactam antibiotic with known low oral bioavailability, was used as a model drug and associated in
various molar ratios with the liposaccharide derivatives by lyophilisation. ITC measurements were
performed to determine the critical micelle concentration and binding affinity of the amphiphilic
conjugates and led to two ratios being considered for further examinations, respectively 1:1 and 1:2
drug/liposaccharide.
Antimicrobial assays revealed that the minimum inhibitory concentration of drug was practically
unchanged when piperacillin was combined with the liposaccharide derivatives. When examining the
effect of the tested conjugates against human red blood cells, an increase of haemolytic activity to
levels similar to SDS was observed in the case of Pip-GC12C12, yet the levels of toxicity remained low
when piperacillin and the liposaccharide derivatives were tested alone; the values observed denoted
a direct correlation between the lipophilicity of the conjugates and their haemolytic activity. The in
vitro evaluation of the synthesised associates in Caco-2 monolayers showed that apparent
membrane permeability values were significantly improved with three formulations, Pip-GC12 (1:1),
Pip-GC12C12 (1:1) and Pip-GC12C12 (1:2). The latter displayed in vitro permeability coefficients nearly
forty times higher than the parent piperacillin drug alone. Unfortunately, these promising results
were not confirmed in vivo. Current research is now being focused on investigating and
characterising the nature of the interactions between the drug and its counter-ionic liposaccharide
derivative, as well as their stability at various pH values.
ACKNOWLEDGEMENTS
Page 9 of 20
John Wiley & Sons, Inc.
Journal of Pharmaceutical Sciences
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
11. ForPeerReview
This work was supported by an ARC project grant (DP0558334). The authors wish to thank Prof
Michael F. Jennings for his kind assistance in providing facilities and equipment to conduct the
microbiology experiments, and Mr Michael Moore for his help with handling animals.
REFERENCES
1. Trapani A, Garcia-Fuentes M, Alonso MJ. 2008. Novel drug nanocarriers combining hydrophilic
cyclodextrins and chitosan. Nanotechnology 19(18):185101/185101-185101/185110.
2. Cano-Cebrian MJ, Zornoza T, Granero L, Polache A. 2005. Intestinal absorption enhancement
via the paracellular route by fatty acids, chitosans and others: A target for drug delivery. Curr
Drug Deliv 2(1):9-22.
3. Shaji J, Patole V. 2008. Protein and Peptide Drug Delivery: Oral Approaches. Indian J Pharm Sci
70(3):269-277.
4. Touitou E, Barry BW. 2006. Enhancement in Drug Delivery. ed.: CRC Press. p 633.
5. Pouton CW, Porter CJH. 2008. Formulation of lipid-based delivery systems for oral
administration: Materials, methods and strategies. Adv Drug Deliv Rev 60(6):625-637.
6. Wong A, Toth I. 2001. Lipid, Sugar and Liposaccharide Based Delivery Systems. Curr Med Chem
8:1123-1136.
7. Bastin RJ, Bowker MJ, Slater BJ. 2000. Salt Selection and Optimisation Procedures for
Pharmaceutical New Chemical Entities. Organic Process Research & Development 4(5):427-
435.
8. Neubert R. 1989. Ion-pair transport across membranes. Pharm Res 6(9):743-747.
9. Violette A, Cortes DAF, Bergeon JA, Falconer RA, Toth I. 2008. Optimized LC-MS/MS
quantification method for the detection of piperacillin and application to the development of
charged liposaccharides as oral penetration enhancers. Int J Pharm 351(1-2):152-157.
10. Abdelrahim AS, Ziora ZM, Bergeon JA, Moss AR, Toth I. 2009. Synthesis and calorimetric
titration of new glucolipopeptides as potential cationic penetration enhancers. Tetrahedron
((submitted)).
11. Kyte J, Doolittle RF. 1982. A simple method for displaying the hydropathic character of a
protein. J Mol Biol 157(1):105-132.
12. Andrews JM. 2001. Determination of minimum inhibitory concentrations. J Antimicrob
Chemoth 48:5-16.
13. Nolting A, DallaCosta T, Rand KH, Derendorf H. 1996. Pharmacokinetic pharmacodynamic
modeling of the antibiotic effect of piperacillin in vitro. Pharm Res 13(1):91-96.
14. Hoogkampkorstanje JAA, Westerdaal NAC. 1979. Activity and synergy of piperacillin and
aminoglycosides against Pseudomonas-Aeruginiosa. A Van Leeuw J Microb 45(4):617-618.
15. Korvick JA, Yu VL. 1991. Antimicrobial agent therapy for Pseudomonas aeruginosa. Antimicrob
Agents Chemother 35(11):2167-2172.
16. Pignatello R, Noce C, Campisi A, Acquaviva R, Bucolo C, Puglisi G, Toth I. 2007. Evaluation of
Cell Tolerability of a Series of Lipoamino Acids Using Biological Membranes and a
Biomembrane Model. Curr Drug Deliv 4:109-121.
17. Ross BP, Braddy AC, McGeary RP, Blanchfield JT, Prokai L, Toth I. 2004. Micellar aggregation
and membrane partitioning of bile salts, fatty acids, sodium dodecyl sulfate, and sugar-
conjugated fatty acids: Correlation with hemolytic potency and implications for drug delivery.
Molecular Pharmaceutics 1(3):233-245.
18. Amin K, Dannenfelser RM. 2006. In vitro hemolysis: Guidance for the pharmaceutical scientist.
J Pharm Sci 95(6):1173-1176.
19. Artursson P, Palm K, Luthman K. 2001. Caco-2 monolayers in experimental and theoretical
predictions of drug transport. Adv Drug Deliv Rev 46(1-3):27-43.
Page 10 of 20
John Wiley & Sons, Inc.
Journal of Pharmaceutical Sciences
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
12. ForPeerReview
20. BriskeAnderson MJ, Finley JW, Newman SM. 1997. The influence of culture time and passage
number on the morphological and physiological development of Caco-2 cells. Proceedings of
the Society for Experimental Biology and Medicine 214(3):248-257.
21. Donna AV. 2008. Variability in Caco-2 and MDCK cell-based intestinal permeability assays. J
Pharm Sci 97(2):712-725.
Page 11 of 20
John Wiley & Sons, Inc.
Journal of Pharmaceutical Sciences
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
14. ForPeerReview
Table 2. Area Under the Curve (AUC120) values for the in vivo pharmacokinetics profile of
piperacillin alone (oral and i.v.) and in association with liposaccharide derivatives GC12 and
GC12C12. Results are given as mean and relative values against intravenous piperacillin levels.
123x61mm (150 x 150 DPI)
Page 13 of 20
John Wiley & Sons, Inc.
Journal of Pharmaceutical Sciences
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
17. ForPeerReview
Figure 3. MICs of piperacillin alone and formulated with the synthesised liposaccharide derivatives
for two Gram-negative bacterial strains, E. coli and P. aeruginosa. Concentrations were determined
by optical density measurements at 600 nm after 24 hr incubation in bacterial culture medium at
37°C. (Values given as mean ± SEM, n≥3)
254x190mm (150 x 150 DPI)
Page 16 of 20
John Wiley & Sons, Inc.
Journal of Pharmaceutical Sciences
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
18. ForPeerReview
Figure 4. Haemolytic activity measured against hRBCs at 37°C over 1hr of piperacillin (alone and
with GC12C12) and the synthesised liposaccharide derivatives in PBS. The percentage of haemolysis
was calculated by absorbance readings at 540 nm (results given as mean ± SEM, n=3)
229x162mm (150 x 150 DPI)
Page 17 of 20
John Wiley & Sons, Inc.
Journal of Pharmaceutical Sciences
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
19. ForPeerReview
Figure 5. Apparent permeability coefficients determined in 21-28 day old monolayers of Caco-2 cells
(passage 31-40) over a 150 min period at 37°C (Results given +/- SEM, n=2-3; 4 wells/exp).
254x190mm (150 x 150 DPI)
Page 18 of 20
John Wiley & Sons, Inc.
Journal of Pharmaceutical Sciences
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
20. ForPeerReview
Figure 6a. In vivo pharmacokinetics of piperacillin sodium administered intravenously at 50 mg/kg
in saline (0.9 % NaCl) over a 2h period; piperacillin concentration in blood was determined by LC-
MS/MS (Results given +/- SEM, n=3-5).
297x210mm (150 x 150 DPI)
Page 19 of 20
John Wiley & Sons, Inc.
Journal of Pharmaceutical Sciences
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
21. ForPeerReview
Figure 6b. In vivo absorption and pharmacokinetics of oral formulations of piperacillin, alone or in
association with liposaccharide derivatives GC12 and GC12C12, in 1:1 and 1:2 ratios in water + 5%
DMSO, over a two hour period. A dose equivalent to 50 mg piperacillin was administered by oral
gavage to 300-350 g Sprague-Dawley rats and piperacillin concentration in blood determined by LC-
MS/MS (Results given +/- SEM, n=3-5).
297x210mm (150 x 150 DPI)
Page 20 of 20
John Wiley & Sons, Inc.
Journal of Pharmaceutical Sciences
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60